Guardant Health to showcase new data at ESMO 2022 demonstrating utility of its portfolio of blood tests for advanced-stage cancer patients

PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health will showcase data at ESMO 2022 demonstrating the utility of its portfolio of blood tests for advanced-stage cancer patients.

Click to view original post